AETHLON MEDICAL, INC. Debt Conversion, Converted Instrument, Amount
AETHLON MEDICAL, INC. (AEMD) reported Debt Conversion, Converted Instrument, Amount of $80.00 thousand for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-08-10
- AETHLON MEDICAL, INC. debt conversion, converted instrument, amount for the quarter ending 2017-06-30 was $80.00K.
- AETHLON MEDICAL, INC. debt conversion, converted instrument, amount for the quarter ending 2016-12-31 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month |
|---|---|---|---|
| 2017-06-30 | $80.00K 10-Q · filed 2017-08-10 | ||
| 2016-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-10 | $30.00K 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $30.00K 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |